Premier Biologics Manufacturing Conference for the Biopharma Community
Premier Biologics Manufacturing Conference for the Biopharma Community
Catch the Latest Innovations Driving the Biologics Industry
20th-21st Feb 2024 |London, UK
0+
Attendees
0+
Companies
0+
Speakers
0+
In-Person Networking Hours
0+
Case Studies
The Concept
Biologics Manufacturing 5.0 2024, is a part of the Biologics Manufacturing World Series with a focus on AI and digitalization's profound impact on bioprocessing.
With a decade of successful operations, the Biologics Manufacturing World Series has firmly established itself as a prominent player in the industry. At the forefront of this series, is a conference poised to redefine the future of biopharmaceutical manufacturing. In an era where the convergence of cutting-edge technologies, AI and digitalization are reshaping industries, we bring together global biopharmas to explore the transformative potential of Industry 5.0 in Biologics Manufacturing.
Our conference agenda covers vital themes: AI for continuous manufacturing, real-time modeling in commercial production, and cloud-based collaboration. We also explore Cell Line Development, Raw Materials, ICH guidelines, streamlined processing, continuous manufacturing integration, and process intensification. This strategy enhances efficiency and productivity, involving process modeling, control, and advanced analytics, offering cost reduction and higher titers while maintaining quality.
This 3-day event will bring together industry leaders from pharma, biotech, academia, and solution providers to foster high-level participation and facilitate meaningful dialogue. Our conference program includes masterclasses, panels, presentations, and breakouts, uniting forward-thinking leaders from various sectors to discuss key topics in Bioprocessing and Smart Manufacturing. We'll delve into major challenges, innovations, and emerging technologies.
Speakers 2024
Biologics Manufacturing 5.0 Agenda
Bioprocessing 5.0: Status and Development of Digital Transformation in Biomanufacturing
AI in Biomanufacturing
Upstream Processing
Advancements in Cell Line Development, Culture Media, and Raw Materials.
Analytics & Quality
Downstream Processing
Streamlined Processing, Purification Advances, and Efficient Tech Transfer.
Novel Therapeutic Modalities
AI for QbD and Supply Chain Risk
AI in Process Verification & Antibody Design
Continuous & Integrated Processing
2024 Sponsors
Exhibitor
Exhibitor
Technology Showcase Sponsor
Past #BME22 Sponsors & Exhibitors
Gold Sponsor
Silver Sponsor
Associate Sponsor
CMO Showcase Sponsor
Advertiser
Catch The Limited Super Access In Time To Save BIG!
Service & Solution Providers
End users
Event Materials
European Big Pharma Distribution
CDMO Geographical Distribution Infographic
It was great to attend the session physically, and have some exchange with industry players and exchange ideas. Thanks IMAPAC for great organisation!
Sanofi
KOH WEI JET, EVF Project Process Manufacturing Leader
Great forum for face to face interactions and for exchange of ideas and information.
WuXi Biologics
Chris Lee, Site Head, Singapore Development and Manufacturing
A well organized ambitious meeting. I hope it will continue to develop in the future.
GSK Vaccines
Jean-Francois Dierick, Strategic Analytical Validation and Lifecycle Lead, Analytical Research and Development
This conference was long overdue in Singapore and critical to making sure that CCT understands current challenges facing our Asian based clients. This allows us to quickly provide new or turn-key solutions and products that meet their needs.
Cold Chain Technologies
Regional Commercial Director
BMA 2022 was an excellently organised event and as a sponsor, participating was very valuable in meeting new connections and engaging with existing customers & contacts. I would recommend anyone involved in the regional biologics industry to participate in the event.
MasterControl
Ciaran O'Keeffe, Director, Business Development & Channel Sales
With the many restrictions and the need to hold the event onsite and online, I do think this event is well planned and held. Easy registration. Spacious, simple and professional settings. All the staffs are very friendly and helpful too. Thank you!
West Pharmaceutical Services
Sr. Technical Account Specialist
Bioworkshops appreciate the effort IMAPAC invested to restore a strong In-person participation to this hybrid event, bringing together many of the biologics manufacturing leaders from Asia along and global experts.
Bioworkshops Limited
Nick Kotlarski, President, VP of BioManufacturing
